Quick Answer
Bone Biologics Corp reported Net Income Loss of -$3.11 million for the year ending 2025.
- Bone Biologics Corp showed an increase of +24.4% in Net Income Loss from 2024 to 2025.
- This data is from Bone Biologics Corp's annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2007 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: -$2.53 million | Q1 2018: -$1.45 million | Q2 2018: -$1.26 million | Q3 2018: -$241.7 thousand | Q1 2019: -$1.41 million | Q2 2019: -$925.6 thousand | Q3 2019: -$561.4 thousand | Q1 2020: -$596.9 thousand | Q2 2020: -$380.0 thousand | Q3 2020: -$394.0 thousand | Q1 2021: -$431.7 thousand | Q2 2021: -$491.9 thousand | Q3 2021: -$509.3 thousand | Q1 2022: -$689.5 thousand | Q2 2022: -$469.3 thousand | Q3 2022: -$1.22 million | Q1 2023: -$3.71 million | Q2 2023: -$1.77 million | Q3 2023: -$1.92 million | Q1 2024: -$866.0 thousand | Q2 2024: -$783.7 thousand | Q3 2024: -$941.0 thousand | Q1 2025: -$1.02 million | Q2 2025: -$740.5 thousand | Q3 2025: -$666.7 thousand.
- Over the full 20 years of available data (2007 to 2025), Bone Biologics Corp's Net Income Loss has declined by 14,146.4%.
- Historical annual values: Fiscal year 2025: -$3.11 million | Fiscal year 2024: -$4.11 million | Fiscal year 2023: -$8.95 million | Fiscal year 2022: -$1.48 million | Fiscal year 2021: -$1.61 million | Fiscal year 2020: -$1.82 million | Fiscal year 2019: -$3.42 million | Fiscal year 2018: -$4.43 million | Fiscal year 2017: -$7.05 million | Fiscal year 2016: -$25.88 million | Fiscal year 2015: -$13.88 million | Fiscal year 2014: -$4.42 million | Fiscal year 2013: -$1.08 million | Fiscal year 2013: -$5.2 thousand | Fiscal year 2012: -$5.6 thousand | Fiscal year 2011: -$4.9 thousand | Fiscal year 2010: -$3.6 thousand | Fiscal year 2009: -$10.3 thousand | Fiscal year 2008: -$13.3 thousand | Fiscal year 2007: -$21.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: